Conventus Orthopaedics received FDA 510(k) clearance to market its Conventus Cage™ DU (Distal Ulna) and PU (Proximal Ulna) systems for fracture repair.
The 3-dimensional Nitinol-based cage technology expands within bone to support stable fixation and prevent collapse of the repair.
These latest applications represent the fourth and fifth cleared indications for Conventus since 2013.
Conventus Orthopaedics received FDA 510(k) clearance to market its Conventus Cage™ DU (Distal Ulna) and PU (Proximal Ulna) systems for fracture repair.
The 3-dimensional Nitinol-based cage technology expands within bone to support stable fixation and prevent collapse of the repair.
These latest applications represent the fourth and fifth...
Conventus Orthopaedics received FDA 510(k) clearance to market its Conventus Cage™ DU (Distal Ulna) and PU (Proximal Ulna) systems for fracture repair.
The 3-dimensional Nitinol-based cage technology expands within bone to support stable fixation and prevent collapse of the repair.
These latest applications represent the fourth and fifth cleared indications for Conventus since 2013.
Copy to clipboard 
